Heart failure & cardiomyopathies
Design and Rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA-HF)
Study context
- Population
- Acute decompensated heart failure (ADHF) with congestion, home diuretic dose ≥80 mg furosemide (or equivalent) and elevated natriuretic peptidesmaximum 50 planned
- Primary endpoint
- Safety (short- and long-term) and feasibility of the procedure
Methodological detailsmulticentre, Key exclusions: anatomical abnormalities, inability to undergo systemic anticoagulation, Congestion indexes assessed prospectively; descriptive statistics
- Multicentre
- Key exclusions: anatomical abnormalities, inability to undergo systemic anticoagulation
- Congestion indexes assessed prospectively; descriptive statistics
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Design and Rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA-HF). ESC Heart Fail. Published 24 December 2024. doi:10.
Summarised from the published abstract; every number is checked against it